미국의 DNA 합성 시장 규모, 점유율, 동향 분석 보고서 : 서비스 유형별, 용도별, 최종 용도별, 부문별 예측(2025-2033년)

U.S. DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Application (Research Development, Diagnostics), By End Use, And Segment Forecasts, 2025 - 2033

US $ 3,950 ￦ 5,703,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 4,950 ￦ 7,146,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 6,950 ￦ 10,034,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

미국의 DNA 합성 시장 요약

미국의 DNA 합성 시장 규모는 2024년 12억 5,000만 달러로 평가되었습니다. 2033년에는 46억 2,000만 달러에 달하고, 2025-2033년 15.93%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이러한 고성장의 배경에는 합성생물학, 맞춤의료, 생명공학 연구 분야 수요 증가가 있습니다. 유전자 편집 기술의 발전과 미국의 DNA 합성 비용 감소는 시장 확대를 더욱 가속화하고 있습니다. 미국은 활발한 연구개발 투자와 탄탄한 생명공학 인프라를 바탕으로 세계 유전체 기술 혁신에서 중요한 역할을 하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 미국의 DNA 합성 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/보조적인 시장 전망.
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 미국의 DNA 합성 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 미국의 DNA 합성 시장 : 서비스 유형별 추정 및 동향 분석

• 부문 대시보드
• 미국의 DNA 합성 시장 변동 분석 : 서비스 유형별
• 미국의 DNA 합성 시장 규모와 동향 분석 : 서비스 유형별, 2021년-2033년
• 올리고뉴클레오티드 합성
  • 유형별
  • 길이별
• 유전자 합성
  • 유형별
  • 길이별

제5장 미국의 DNA 합성 시장 : 용도별 추정 및 동향 분석

• 부문 대시보드
• 미국의 DNA 합성 시장 변동 분석 : 용도별
• 미국의 DNA 합성 시장 규모와 동향 분석 : 용도별, 2021년-2033년
• 연구개발
  • 올리고뉴클레오티드 합성
  • 유전자 합성
• 진단
• 치료제
  • RNAi 요법
  • 안티센스 및 올리고뉴클레오티드 기반 치료법
  • 기타

제6장 미국의 DNA 합성 시장 : 최종 용도별 추정 및 동향 분석

• 부문 대시보드
• 미국의 DNA 합성 시장 변동 분석 : 최종 용도별
• 미국의 DNA 합성 시장 규모와 동향 분석 : 최종 용도별, 2021년-2033년
• 바이오의약품 및 진단 기업
• 학술연구기관
• 수탁연구기관

제7장 경쟁 구도

• 기업/경쟁 분류
• 전략 매핑
• 기업 시장 현황 분석, 2024년
• 기업 개요/상장기업
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience
  • BIONEER CORPORATION
  • Eton Bioscience, Inc
  • LGC Biosearch Technologies
  • IBA Lifesciences GmbH
  • Eurofins Scientific
  • Integrated DNA Technologies, Inc.
  • Quintara Biosciences
  • GenScript

LSH

영문 목차

영문목차

U.S. DNA Synthesis Market Summary

The U.S. DNA synthesis market size was estimated at USD 1.25 billion in 2024 and is projected to reach USD 4.62 billion by 2033, expanding at a CAGR of 15.93% from 2025 to 2033. This high growth is driven by increasing demand in synthetic biology, personalized medicine, and biotechnology research. Advancements in gene editing technologies and declining costs of U.S. DNA synthesis are further accelerating market expansion. The U.S. remains a key player in global genomic innovation, supported by strong investment in R&D and a well-established biotech infrastructure.

U.S. DNA Synthesis Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. DNA synthesis market on the basis of service type, application, and end use.

• Service Type Outlook (Revenue, USD Million, 2021 - 2033)
• Oligonucleotide Synthesis
  • By Type
  • Standard Oligonucleotide Synthesis
  • Custom Oligonucleotide Synthesis
  • By Length
  • Less than 50 nt
  • 51-100 nt
  • 101-150 nt
  • More than 150 nt
• Gene Synthesis
  • By Type
  • Custom Gene Synthesis
  • Gene Library Synthesis
  • By Length
  • Less than 500 nt
  • 501-1000 nt
  • 1001-1500 nt
  • 1501-2000 nt
  • 2001-2500 nt
  • More than 2500 nt
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Research and Development
  • Oligonucleotide Synthesis
  • PCR
  • NGS
  • CRISPR
  • Cloning and Mutagenesis
  • Others
  • Gene Synthesis
  • Synthetic Biology
  • Vaccine Development
  • Genetic Engineering
  • Others
• Diagnostics
• Therapeutics
  • RNAi Therapies
  • Antisense Oligonucleotide-based Therapies
  • Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical and Diagnostics Companies
• Academic and Research Institutes
• Contract Research Organizations

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service Type
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. DNA Synthesis Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. DNA synthesis Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. U.S. DNA Synthesis Market: Service Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. DNA Synthesis Market Service Type Movement Analysis
• 4.3. U.S. DNA Synthesis Market Size & Trend Analysis, by Service Type, 2021 to 2033 (USD Million)
• 4.4. Oligonucleotide synthesis
  • 4.4.1. Oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.2. By Type
    • 4.4.2.1. Standard oligonucleotides synthesis
      • 4.4.2.1.1. Standard oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2.2. Custom oligonucleotide synthesis
      • 4.4.2.2.1. Custom oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.3. By Length
    • 4.4.3.1. Less than 50nt
      • 4.4.3.1.1. Less than 50nt market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3.2. 51-100nt
      • 4.4.3.2.1. 51-100nt market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3.3. 101-150nt
      • 4.4.3.3.1. 101-150nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3.4. More than 150nt
      • 4.4.3.4.1. More than 150nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Gene synthesis
  • 4.5.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5.2. By Type
    • 4.5.2.1. Custom gene synthesis
      • 4.5.2.1.1. Custom gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.2.2. Gene library synthesis
      • 4.5.2.2.1. Gene library synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5.3. By Length
    • 4.5.3.1. Less than 500nt
      • 4.5.3.1.1. Less than 500nt market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3.2. 501-1000nt
      • 4.5.3.2.1. 501-1000nt market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3.3. 1001-1500nt
      • 4.5.3.3.1. 1001-1500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3.4. 1501-2000nt
      • 4.5.3.4.1. 1501-2000nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3.5. 2001-2500nt
      • 4.5.3.5.1. 2001-2500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3.6. More than 2500nt
      • 4.5.3.6.1. More than 2500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. DNA Synthesis Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. DNA Synthesis Market Application Movement Analysis
• 5.3. U.S. DNA Synthesis Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Research & Development
  • 5.4.1. Research & development market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Oligonucleotide synthesis
    • 5.4.2.1. Oligonucleotide synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.2. PCR
      • 5.4.2.2.1. PCR synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.3. NGS
      • 5.4.2.3.1. NGS synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.4. CRISPR
      • 5.4.2.4.1. CRISPR synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.5. Cloning and mutagenesis
      • 5.4.2.5.1. Cloning and mutagenesis synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.6. Others
      • 5.4.2.6.1. Others synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.3. Gene synthesis
    • 5.4.3.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3.2. Synthetic biology
      • 5.4.3.2.1. Synthetic biology tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3.3. Vaccine development
      • 5.4.3.3.1. Vaccine development synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3.4. Genetic engineering
      • 5.4.3.4.1. Genetic engineering synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3.5. Others
      • 5.4.3.5.1. Others synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Diagnostics
  • 5.5.1. Diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Therapeutics
  • 5.6.1. Therapeutics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.2. RNAi therapies
    • 5.6.2.1. RNAi therapies market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.3. Antisense and oligonucleotide-based therapies
    • 5.6.3.1. Antisense and oligonucleotide-based therapies market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.4. Others
    • 5.6.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. DNA Synthesis Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. DNA Synthesis Market End Use Movement Analysis
• 6.3. U.S. DNA Synthesis Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Biopharmaceutical & Diagnostic Companies
  • 6.4.1. Biopharmaceutical & diagnostic companies market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Contract Research Organizations
  • 6.6.1. Contract Research Organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Thermo Fisher Scientific Inc.
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Service benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Twist Bioscience
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Service benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. BIONEER CORPORATION
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Service benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Eton Bioscience, Inc
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Service benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. LGC Biosearch Technologies
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Service benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. IBA Lifesciences GmbH
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Service benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Eurofins Scientific
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Service benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Integrated DNA Technologies, Inc.
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Service benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Quintara Biosciences
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Service benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. GenScript
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Service benchmarking
    • 7.4.10.4. Strategic initiatives

관련자료